Correlation Between Morgan Stanley and Namwiwat Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and Namwiwat Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and Namwiwat Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Morgan Stanley Direct and Namwiwat Medical, you can compare the effects of market volatilities on Morgan Stanley and Namwiwat Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of Namwiwat Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and Namwiwat Medical.

Diversification Opportunities for Morgan Stanley and Namwiwat Medical

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Morgan and Namwiwat is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and Namwiwat Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Namwiwat Medical and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with Namwiwat Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Namwiwat Medical has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and Namwiwat Medical go up and down completely randomly.

Pair Corralation between Morgan Stanley and Namwiwat Medical

Given the investment horizon of 90 days Morgan Stanley Direct is expected to generate 0.75 times more return on investment than Namwiwat Medical. However, Morgan Stanley Direct is 1.33 times less risky than Namwiwat Medical. It trades about 0.14 of its potential returns per unit of risk. Namwiwat Medical is currently generating about -0.06 per unit of risk. If you would invest  1,953  in Morgan Stanley Direct on September 15, 2024 and sell it today you would earn a total of  165.00  from holding Morgan Stanley Direct or generate 8.45% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.31%
ValuesDaily Returns

Morgan Stanley Direct  vs.  Namwiwat Medical

 Performance 
       Timeline  
Morgan Stanley Direct 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley Direct are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating fundamental indicators, Morgan Stanley may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Namwiwat Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Namwiwat Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent primary indicators, Namwiwat Medical is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Morgan Stanley and Namwiwat Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Morgan Stanley and Namwiwat Medical

The main advantage of trading using opposite Morgan Stanley and Namwiwat Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, Namwiwat Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Namwiwat Medical will offset losses from the drop in Namwiwat Medical's long position.
The idea behind Morgan Stanley Direct and Namwiwat Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments